How can I invest like Cathie Wood in 2023?

Dr James Fox investigates how he could invest like the ‘best’ investor of 2020, Cathie Wood. So what would it take, and should he do it?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

2023 concept with a lightbulb replacing the zero

Image source: Getty Images

Cathie Wood is the founder, CEO, and CIO of ARK Invest, an asset manager that invests in disruptive innovation — essentially a type of growth stock.

In 2020, Wood was named best stock-picker of the year by Bloomberg News editor-in-chief emeritus Matthew A Winkler.

Within her Ark portfolio — named after the Ark of the Covenant — Wood has six actively managed ETFs (Exchange Traded Funds), two index ETFs and one ETF venture fund.

During 2020, all six ARK ETFs notched returns greater than 100% — while the S&P 500 grew a mere 16%.

So, how can I invest like the best investor of 2020 in 2023?

Investing in disruptors

Wood’s portfolios focus on high-impact innovations, such as artificial intelligence, DNA sequencing, robotics, energy storage, and blockchain technology. These are the main five areas that Wood believes will be the prominent areas of growth and change for the global economy.

So, if I want to invest like Cathie Wood, I should start with these sectors.

The premise of all of her investments is that the concepts and technologies behind the companies are designed to solve big problems. “Innovation tends to gain traction during difficult times because it solves problems,” the prominent asset manager said in a recent webinar.

These technologies also deliver a cost-cutting element that encourages quick adoption. And that makes sense, innovations that create large-scale efficiencies often generate their own momentum. 

She also takes a fairly short timeline for her investments — just five years. This, she contends, maximises investor returns on these disruptive innovators.

Criticism

However, Wood isn’t immune to criticism. In fact, she’s got rather a lot of it over the last year as her portfolios tanked.

She’s been accused of investing in “concept capital” and companies that cannot turn a profit. Meanwhile, with her portfolios crashing, Cathie Wood has continuing investing in stocks that other investors are shunning, such as Tesla.

Wood has remained steadfast in her support of Elon Musk’s Tesla, insisting it will “dominate” when the world truly transitions to electrification of transport.

Do I want to invest like Wood?

Wood’s flagship fund, Ark Innovation, now lags the S&P 500 over five years after a disastrous 12 months. The fund is down around 63% over the year.

In fact, all of her portfolios have taken massive hits over the past year. As of December, 2022, total assets across Ark’s nine ETFs had slumped to $11.4bn from a peak of $60.3bn in February 2021 — near-$50bn loss.

And, over Wood’s preferred five-year timeline, the returns are either negative or a small upside. 

So, is investing like Wood a good idea for me?

The reality is that 2022 has been a challenging year for the growth sector in general. And I’d suggest that Wood’s investments, which can be rather speculative — especially in treatment and drugs — have suffered more.

Just take a look at biotech stocks like Beam Therapeutics and CRISPR Therapeutics. These companies are phenomenally volatile and there are concerns as to whether the tech will ever make it to market.

I don’t think 2023 will be as bad for Cathie Wood. In fact, I wouldn’t be surprised to see her portfolios push upwards as macroeconomic conditions improve in H2.

However, for me, her approach is far too risky. I’m sticking to value investing and a compound returns strategy.

James Fox has no position in any of the shares mentioned. The Motley Fool UK has recommended CRISPR Therapeutics and Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Stack of one pound coins falling over
Investing Articles

Want to turn your ISA into a passive income machine? These 3 steps help

Christopher Ruane looks at a trio of factors he reckons could help an investor as they aim to earn passive…

Read more »

Investing For Beginners

2 FTSE shares that have been oversold in this stock market correction

Jon Smith reviews the recent market slump and points out a couple of FTSE shares he believes have been oversold…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

As the stock market moves down, I’m taking the Warren Buffett approach!

Rather than getting nervous as markets move around, our writer is looking to the career of Warren Buffett to see…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

Here’s how a stock market crash could be brilliant news for your retirement!

This writer isn't peering into a crystal ball trying to time the next stock market crash. Instead, he's making an…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

Down 93%, should I load up on this penny stock while it’s under 1p?

The small-cap company behind this penny stock is eyeing up a substantial global market opportunity. So why did it crash…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Is Fundsmith Equity still worth holding in a Stocks and Shares ISA or SIPP in 2026?

The performance of the Fundsmith Equity fund has been shocking over the last two years. Is it still smart to…

Read more »

Young female hand showing five fingers.
Investing Articles

5 smart moves to make before the 2025/2026 ISA deadline

Taking advantage of the annual allowance isn’t the only smart move to make before the upcoming ISA deadline, says Edward…

Read more »

Businesswoman calculating finances in an office
Investing Articles

Here’s the dividend forecast for Lloyds shares through to 2028

Can dividend forecasts tell investors much about the outlook for banking shares? Stephen Wright sets out what investors really need…

Read more »